Selected cannabis cultivars modulate glial activation: in vitro and in vivo studies
Abstract Introduction Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system characterized by neuroinflammation, demyelination and axonal loss. Cannabis, an immunomodulating agent, is known for its ability to treat MS effectively. However, due to variations in the prof...
Saved in:
Main Authors: | Sigal Fleisher-Berkovich, Nitzan Sharon, Yvonne Ventura, Valeria Feinshtein, Jonathan Gorelick, Nirit Bernstein, Shimon Ben-Shabat |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-05-01
|
Series: | Journal of Cannabis Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s42238-024-00232-0 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A national study of clinical discussions about cannabis use among Veteran patients prescribed opioids
by: Tauheed Zaman, et al.
Published: (2024-03-01) -
Determining the diagnostic cut-off on the Chinese version of severity of dependence scale for cannabis
by: Albert Kar Kin Chung, et al.
Published: (2025-01-01) -
Cannabis-induced obsessive-compulsive disorder: Is it a paradox?
by: Rashmi Shukla, et al.
Published: (2023-11-01) -
Cannabis mythology: the process of shaping from experience in Nakhon Si Thammarat, Thailand
by: Fareeda Jeh-oh, et al.
Published: (2025-12-01) -
Medical cannabis in the management of musculoskeletal pain: a systematic review of clinical trials
by: Przemysław Płatek, et al.
Published: (2024-12-01)